Abiopharma

🔍 McBee Brannin (Executive)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 40,000 shares of Class A Common Stock (Direct)
  Date: 2026-06-22 | Code: C | equity_swap_involved: 0 | shares_owned_after: 40,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,177 shares of Class A Common Stock at $107.0531 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 37,823.00 | transaction_form_type: 4 | Footnotes: F3, F4, F2
• Sold 2,528 shares of Class A Common Stock at $108.2424 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,295.00 | transaction_form_type: 4 | Footnotes: F3, F5, F2
• Sold 3,151 shares of Class A Common Stock at $109.2096 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,144.00 | transaction_form_type: 4 | Footnotes: F3, F6, F2
• Sold 7,799 shares of Class A Common Stock at $110.2748 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,345.00 | transaction_form_type: 4 | Footnotes: F3, F7, F2
• Sold 12,761 shares of Class A Common Stock at $111.2298 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,584.00 | transaction_form_type: 4 | Footnotes: F3, F8, F2
• Sold 4,304 shares of Class A Common Stock at $112.0395 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,280.00 | transaction_form_type: 4 | Footnotes: F3, F9, F2
• Sold 1,744 shares of Class A Common Stock at $112.97 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,536.00 | transaction_form_type: 4 | Footnotes: F3, F10, F2
• Sold 1,392 shares of Class A Common Stock at $114.5015 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,144.00 | transaction_form_type: 4 | Footnotes: F3, F11, F2
• Sold 1,600 shares of Class A Common Stock at $115.4209 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,544.00 | transaction_form_type: 4 | Footnotes: F3, F12, F2
• Sold 1,888 shares of Class A Common Stock at $116.4805 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 656.00 | transaction_form_type: 4 | Footnotes: F3, F13, F2
• Sold 320 shares of Class A Common Stock at $117.421 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 336.00 | transaction_form_type: 4 | Footnotes: F3, F14, F2
• Sold 336 shares of Class A Common Stock at $119.0 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 12,500 shares of Class A Common Stock (Direct)
  Date: 2026-06-22 | Code: C | equity_swap_involved: 0 | shares_owned_after: 12,500.00 | transaction_form_type: 4 | Footnotes: F1, F15
• Sold 680 shares of Class A Common Stock at $107.0529 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,820.00 | transaction_form_type: 4 | Footnotes: F3, F4, F15
• Sold 790 shares of Class A Common Stock at $108.2424 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,030.00 | transaction_form_type: 4 | Footnotes: F3, F5, F15
• Sold 985 shares of Class A Common Stock at $109.2093 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 10,045.00 | transaction_form_type: 4 | Footnotes: F3, F6, F15
• Sold 2,438 shares of Class A Common Stock at $110.2747 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,607.00 | transaction_form_type: 4 | Footnotes: F3, F7, F15
• Sold 3,988 shares of Class A Common Stock at $111.2299 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,619.00 | transaction_form_type: 4 | Footnotes: F3, F8, F15
• Sold 1,344 shares of Class A Common Stock at $112.0397 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,275.00 | transaction_form_type: 4 | Footnotes: F3, F9, F15
• Sold 545 shares of Class A Common Stock at $112.97 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,730.00 | transaction_form_type: 4 | Footnotes: F3, F10, F15
• Sold 435 shares of Class A Common Stock at $114.5014 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,295.00 | transaction_form_type: 4 | Footnotes: F3, F11, F15
• Sold 500 shares of Class A Common Stock at $115.4209 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 795.00 | transaction_form_type: 4 | Footnotes: F3, F12, F15
• Sold 590 shares of Class A Common Stock at $116.4805 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 205.00 | transaction_form_type: 4 | Footnotes: F3, F13, F15
• Sold 100 shares of Class A Common Stock at $117.421 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 105.00 | transaction_form_type: 4 | Footnotes: F3, F14, F15
• Sold 105 shares of Class A Common Stock at $119.0 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F15
• Sold 40,000 shares of Class B Common Stock (Derivative)
  Date: 2026-06-22 | Code: C | equity_swap_involved: 0 | shares_owned_after: 3,797,227.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 12,500 shares of Class B Common Stock (Derivative)
  Date: 2026-06-22 | Code: C | equity_swap_involved: 0 | shares_owned_after: 523,705.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F15

Footnotes:

• F1: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F2: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.
• F3: The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.63 to $107.62, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.66 to $108.65, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.66 to $109.65, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.66 to $110.65, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.66 to $111.65, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.66 to $112.65, inclusive.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.67 to $113.58, inclusive.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.94 to $114.89, inclusive.
• F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.99 to $115.98, inclusive.
• F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.99, inclusive.
• F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.05 to $117.76, inclusive.
• F15: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.
• REMARKS: This Form 4 is Part 3 of 4 for this reporting person. Transactions by the reporting person are continued on Part 4.